Search Results 1701-1710 of 17927 for STI Prevention

1. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   The purpose of this study is to assess the maximum tolerated dose (MTD) of administering metformin in combination with nelfinavir in patients with relapsed/ ...

2. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

3. Long Term Safety And Efficacy Of Solesta® Injectable Bulking Agent For The Treatment Of Fecal Incontinence (SoFI) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Study to Evaluate an ECG Belt for CRT Response - Mayo Clinic

   The purpose of this study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect ...

5. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Patients in the Palliative Medicine Clinic to Assess Current and Future Therapeutic Relevance - Mayo Clinic

   About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...

6. A Study Of PROMIS-10, PROMIS-CAT-SRI & ESS For Assessing PAP Therapy Response With OSA - Mayo Clinic

   About this study. The purpose of this study is to compare PROMIS-CAT-SRI and PROMIS-10 with the ESS in adults with OSA newly initiated on PAP therapy by ...

7. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

   A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early ...

8. Using Induced-Pluripotent Stem Cells To Model Cancer Therapy-Related Adverse Events - Mayo Clinic

   The purpose of this study is to use patient blood cells to perform individualized in vitro modeling of cancer therapy-related toxicities. Participation ...

9. Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab in Refractory Cancer - Mayo Clinic

   Assessments will also be done to see how the drug acts in the body (pharmacokinetics (PK), pharmacodynamics) and to evaluate potential anti-tumor activity of ...

10. Shared Decision Making For Fibromyalgia Patients - Mayo Clinic

    The purpose of this study is to build the knowledge of in-situ clinical experiences essential to developing decision aids for patients considering treatment ...